The discovery of the BRCA1 and BRCA2 genes advanced risk assessment in families affected by hereditary breast and ovarian cancer, but identification of molecular markers associated with increased breast cancer risk in patients without a family history of breast cancer has remained far more challenging. The gene discussed is BRCA1; the disease is ovarian carcinoma.